share_log

Zevra Therapeutics Presents Five Posters At SSIEM 2024 Symposium Highlighting Arimoclomol's Efficacy In Treating Niemann-Pick Disease Type C And Data On OLPRUVA For Urea Cycle Disorders

Benzinga ·  Sep 6 20:32
Zevra Therapeutics Presents Five Posters At SSIEM 2024 Symposium Highlighting Arimoclomol's Efficacy In Treating Niemann-Pick Disease Type C And Data On OLPRUVA For Urea Cycle Disorders
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment